N-Carbamyl-L-glutamic Acid - CAS 1188-38-1

Carglumic acid is an orphan drug, marketed by Orphan Europe under the trade name Carbaglu. Carglumic acid is used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. The initial daily dose ranges from 100 to 250 mg/kg, adjusted thereafter to maintain normal plasma levels of ammonia.

Catalog Number: R055604

CAS Number: 1188-38-1

PubChem Substance ID:355035953

Molecular Formula: C₆H₁₀N₂O₅

Molecular Weight:190.15

Purity: ≥95%

* For research use only. Not for human or veterinary use.


SynonymsCarbaglu; Carbamino-L-glutamic Acid; Carbamylglutamic Acid; Carglumic Acid; N-Carbamoyl-L-glutamic Acid; N-Carbamoyl-S-glutamic Acid; N-Carbamyl-L-glutamic Acid; OE 312; Ureidoglutaric Acid; N-(Aminocarbonyl)-L-glutamic Acid;


Molecular Formula: C₆H₁₀N₂O₅
Molecular Weight190.15
StorageDesiccate at RT